Literature DB >> 21231814

Experiences on the use of biological drugs in psoriatic arthritis-associated amyloidosis.

K Immonen, M Kauppi, M Hakala.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21231814     DOI: 10.3109/03009742.2010.530294

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  3 in total

Review 1.  Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.

Authors:  Ayush Gupta; Narendra Kumar Bagri; Saroj Kumar Tripathy; Adarsh Barwad; Ravi Hari Phulware; Pankaj Hari
Journal:  Rheumatol Int       Date:  2019-07-04       Impact factor: 2.631

Review 2.  Course and Prognosis of AA Amyloidosis in Patients with Psoriatic Arthritis: Report of Three Cases from a Single Center Cohort and Review of the Literature.

Authors:  Murat Bektaş; Nevzat Koca; Burak Ince; Yasemin Yalçınkaya; Bahar Artım Esen; M Lale Öcal; Ahmet Gül; Murat Inanç
Journal:  Mediterr J Rheumatol       Date:  2022-06-30

3.  Variegate porphyria complicated by systemic AA amyloidosis: a case report.

Authors:  Yoshiki Tsuchiya; Junichi Hoshino; Tatsuya Suwabe; Keiichi Sumida; Rikako Hiramatsu; Koki Mise; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Hayami; Naoki Sawa; Kenji Arizono; Shigeko Hara; Kenmei Takaichi; Takeshi Fujii; Yoshifumi Ubara
Journal:  Amyloid       Date:  2013-10-16       Impact factor: 7.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.